About the NMVB Research Evaluation Panel (REP)
The NMVB Research Evaluation Panel is composed of experts in the fields of mesothelioma and mesothelioma research, NMVB leadership, and a representative from the patient advocacy community. The Research Evaluation Panel is responsible for reviewing Letters of Intent submitted to the NMVB to determine the scientific merit of a proposed project and assess the ability of the Bank to meet the stated specimen requirements of the researcher. In addition to analyzing the proposed study design, the Research Evaluation Panel will consider whether the research question posed is of sufficient significance to warrant use of NMVB specimens.
NMVB REP Voting Members:
 |
Courtney Broaddus, MD Professor of Medicine University of California, San Francisco Chief, Division of Pulmonary and Critical Care Medicine San Francisco General Hospital |
 |
Michele Carbone, MD, PhD Professor of Pathology Thoracic Oncology Program, Cancer Research Center of Hawaii University of Hawaii |
|
|
Joseph R. Testa, PhD Senior Member and Director, Human Genetics Program Fox Chase Cancer Center |
 |
Brooke T. Mossman, PhD Professor of Pathology Director, Environmental Pathology Program University of Vermont, College of Medicine Department of Pathology |
NMVB REP Non-Voting Members:
 |
Michael J. Becich, MD, PhD |
 |
Michael Feldman, MD, PhD |
|
|
Jonathan Melamed, MD Associate Professor. Department of Pathology New York University |
 |
Harvey I. Pass, MD Professor of Surgery and Cardiothoracic Surgery Chief, Division of Thoracic Surgery and Thoracic Oncology Department of Cardiothoracic Surgery Director of Surgical Research NYU School of Medicine and NCI Cancer Center |
|
|
Arjun Pennathur, MD
Surgeon Department of General Thoracic Surgery UPMC St Margaret's University of Pittsburgh Medical Center |